We are live on ! Find out more
RGNX icon

Regenxbio
RGNX

188 hedge funds and large institutions have $896M invested in Regenxbio in 2024 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 60 increasing their positions, 53 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% more call options, than puts

Call options by funds: $2.37M | Put options by funds: $1.36M

74% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 23

25% more capital invested

Capital invested by funds: $717M → $896M (+$179M)

13% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 53

10% more funds holding

Funds holding: 171 → 188 (+17)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

3.87% less ownership

Funds ownership: 90.8% → 86.93% (-3.9%)

Holders
188
Holders Change
+17
Holders Change %
+9.94%
% of All Funds
2.71%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
40
Increased
60
Reduced
53
Closed
23
Calls
$2.37M
Puts
$1.36M
Net Calls
+$1.01M
Net Calls Change
+$1.29M

Top Buyers

1
APM
Avidity Partners Management
Texas
+$23.1M
2
RG
Redmile Group
California
+$14.1M
3
State Street
State Street
Massachusetts
+$8.74M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$7.76M
5
IHAM
Integral Health Asset Management
New York
+$7.74M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$40.9M
2
BlackRock
BlackRock
New York
-$10.8M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$7.17M
4
PA
Perceptive Advisors
New York
-$6.15M
5
JP Morgan Chase
JP Morgan Chase
New York
-$3.86M
Name Holding Trade Value Shares
Change 		Change in
Stake
Assenagon Asset Management
26
Assenagon Asset Management
Luxembourg
$4.8M +$2.15M +120,929 +113%
AI
27
ArchPoint Investors
Florida
$4.73M – – –
Norges Bank
28
Norges Bank
Norway
$4.65M – – –
Principal Financial Group
29
Principal Financial Group
Iowa
$4.56M -$353K -19,812 -8%
Citigroup
30
Citigroup
New York
$3.93M +$2.04M +114,542 +159%
SSA
31
Schonfeld Strategic Advisors
New York
$3.87M +$3.27M +183,795 New
Rafferty Asset Management
32
Rafferty Asset Management
New York
$3.79M +$1.05M +59,035 +49%
Millennium Management
33
Millennium Management
New York
$3.49M +$1.97M +110,498 +200%
Adage Capital Partners
34
Adage Capital Partners
Massachusetts
$3.48M +$2.94M +165,073 New
Bank of America
35
Bank of America
North Carolina
$3.43M +$533K +29,951 +23%
Deutsche Bank
36
Deutsche Bank
Germany
$3.33M +$2.49M +140,025 +771%
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$3.29M -$26.3K -1,480 -0.9%
Mirae Asset Global Investments
38
Mirae Asset Global Investments
South Korea
$3.22M +$1.35M +75,800 +80%
Macquarie Group
39
Macquarie Group
Australia
$3.14M – – –
WP
40
Woodline Partners
California
$3.08M +$2.6M +146,334 New
Invesco
41
Invesco
Georgia
$2.99M -$74.3K -4,176 -3%
UBS Group
42
UBS Group
Switzerland
$2.98M -$121K -6,809 -5%
GTC
43
Ghost Tree Capital
New York
$2.53M +$2.14M +120,000 New
Legal & General Group
44
Legal & General Group
United Kingdom
$2.36M +$29.6K +1,662 +2%
AAA
45
Affinity Asset Advisors
New York
$2.32M +$1.96M +110,000 New
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$2.31M -$31.9K -1,792 -2%
CSS
47
Cubist Systematic Strategies
Connecticut
$2.29M +$1.32M +74,313 +217%
Citadel Advisors
48
Citadel Advisors
Florida
$2.29M -$1.84M -103,547 -49%
HWAM
49
Hennion & Walsh Asset Management
New Jersey
$2.24M +$580K +32,584 +44%
N
50
Nuveen
North Carolina
$2.23M – – –
1
2
3 4 5

RGNX Hedge Fund Activity: Q1 2024 in Review

188 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q1 2024, worth a combined $896M — up 25% from $717M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new RGNX positions and 23 closed out — a net gain of 17 holders — while 60 added to existing stakes and 53 trimmed.

The largest buyer was Avidity Partners Management, opening a new position worth an estimated $23.1M. The largest seller was Morgan Stanley, cutting an estimated $40.9M.

  • 188 institutional investors held Regenxbio (RGNX) as of Q1 2024, up from 171 in Q4 2023.
  • Funds reported $896M of Regenxbio stock for Q1 2024, up 25% quarter-over-quarter.
  • 40 funds opened new Regenxbio positions in Q1 2024 and 23 closed out, a net change of +17 holders.
  • The largest Regenxbio buyer in Q1 2024 was Avidity Partners Management, an estimated $23.1M added.
  • The largest Regenxbio seller in Q1 2024 was Morgan Stanley, an estimated $40.9M sold.

Based on aggregated 13F filings for Q1 2024.